Meet with us at Society for Immunotherapy of Cancer (SITC) Annual Meeting!
SITC 2026 brings together the global cancer immunotherapy community to exchange the latest science, clinical insights, and approaches shaping the future of immuno-oncology. Premier Research will be in Phoenix to connect with researchers and industry leaders advancing the next generation of cancer therapies.
From emerging immunotherapies and biomarker-driven approaches to complex early- and late-phase studies, our oncology experts combine deep therapeutic knowledge with integrated clinical development and medical affairs capabilities. Premier supports oncology programs across study design, clinical execution, patient and site strategy, medical monitoring, safety oversight, and regulatory readiness—helping teams navigate scientific and operational complexity throughout development.
Connect with our team at SITC to discuss your immuno-oncology program and how the right combination of medical, scientific, and operational expertise can help move development forward.
On-Site
- Gwyn Bebb, Senior Vice President, Global Head of Medical Affairs & Medical Oncology Strategy
- Ashley Herrick, Vice President, Head of Immuno-Oncology
- Rusty Wall, Executive Director, Business Development
Fill out the form above to schedule a meeting with our on-site team.
Connect with our team at SITC to discuss your immuno-oncology development strategy, clinical trial priorities, and opportunities to strengthen execution from study design through delivery.
